Leukemic stem cells and measurable residual disease in AML:An emerging new outcome parameter
العنوان: | Leukemic stem cells and measurable residual disease in AML:An emerging new outcome parameter |
---|---|
المؤلفون: | Zeijlemaker, W |
المصدر: | Zeijlemaker, W 2017, ' Leukemic stem cells and measurable residual disease in AML : An emerging new outcome parameter ', PhD, Vrije Universiteit Amsterdam . Zeijlemaker, W 2017, ' Leukemic stem cells and measurable residual disease in AML : An emerging new outcome parameter ', Doctor of Philosophy, VU Vrije Universiteit . < http://hdl.handle.net/1871.1/7e5b2666-8a23-4d19-94e1-9c5fe2c74e33 > |
سنة النشر: | 2017 |
مصطلحات موضوعية: | minimal/measurable residual disease, acute myeloid leukemia, leukemic stem cells |
وصف الملف: | application/pdf |
اللغة: | English |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f3054f601965acb176716780cb093f9c |
حقوق: | OPEN |
رقم الأكسشن: | edsair.dedup.wf.001..f3054f601965acb176716780cb093f9c |
قاعدة البيانات: | OpenAIRE |
الوصف غير متاح. |